Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.

Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Gentry LO, Williams T, Kontoyiannis DP, Karl CL, Bodey GP.

Clin Infect Dis. 1996 Nov;23(5):964-72. Review.

PMID:
8922787
2.

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.

Anaissie EJ, Vartivarian SE, Abi-Said D, Uzun O, Pinczowski H, Kontoyiannis DP, Khoury P, Papadakis K, Gardner A, Raad II, Gilbreath J, Bodey GP.

Am J Med. 1996 Aug;101(2):170-6.

PMID:
8757357
3.

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.

Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC.

Am J Med. 2000 Mar;108(4):282-9.

PMID:
11014720
4.
5.

[Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].

Cobo Reinoso P, Aguado García JM, Lumbreras Bermejo C, Pérez Vela JL, Caballero Cubedo R, Sanz Sanz F, Noriega Rodríguez AR.

Rev Clin Esp. 1997 Dec;197(12):799-803. Spanish.

PMID:
9477669
6.

Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.

Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, D'Antonio D, Ricci P, Carotenuto M, Liso V, Nosari AM, Barbui T, Fasola G, Mandelli F; GIMEMA Infection Program.

Ann Intern Med. 1994 Jun 1;120(11):913-8.

PMID:
8172437
7.

Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.

Viscoli C, Castagnola E, Van Lint MT, Moroni C, Garaventa A, Rossi MR, Fanci R, Menichetti F, Caselli D, Giacchino M, Congiu M.

Eur J Cancer. 1996 May;32A(5):814-20.

PMID:
9081359
9.

Use of fluconazole in the treatment of candidal endophthalmitis.

Akler ME, Vellend H, McNeely DM, Walmsley SL, Gold WL.

Clin Infect Dis. 1995 Mar;20(3):657-64. Review.

PMID:
7756492
10.

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.

Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G.

J Antimicrob Chemother. 1993 Jun;31(6):973-84.

PMID:
8360134
11.

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, et al.

N Engl J Med. 1994 Nov 17;331(20):1325-30.

12.

Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.

Fichtenbaum CJ, Zackin R, Rajicic N, Powderly WG, Wheat LJ, Zingman BS.

AIDS. 2000 May 5;14(7):845-52.

PMID:
10839593
13.

Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever--preliminary observations from a pilot, exploratory study.

Ellis ME, Halim MA, Spence D, Ernst P, Clink H, Kalin M, Baillie F, Greer W.

J Infect. 1995 Mar;30(2):141-6.

PMID:
7636280
14.

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Kullberg BJ, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Rex JH, Cleary JD, Rubinstein E, Church LW, Brown JM, Schlamm HT, Oborska IT, Hilton F, Hodges MR.

Lancet. 2005 Oct 22-28;366(9495):1435-42.

PMID:
16243088
15.

Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria.

Fan-Havard P, O'Donovan C, Smith SM, Oh J, Bamberger M, Eng RH.

Clin Infect Dis. 1995 Oct;21(4):960-5.

PMID:
8645847
16.

Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients.

Lake DE, Kunzweiler J, Beer M, Buell DN, Islam MZ.

Chemotherapy. 1996 Jul-Aug;42(4):308-14.

PMID:
8804799
17.

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, Borleffs JC, Allworth T, Kauffmann RH, Jones P, Kroon FP, Verbrugh HA, de Marie S.

AIDS. 1997 Oct;11(12):1463-71.

PMID:
9342068
18.

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ, Buell DN.

Ann Intern Med. 1993 Apr 1;118(7):495-503.

PMID:
8442620
19.

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clin Infect Dis. 2003 May 15;36(10):1221-8. Epub 2003 May 8.

PMID:
12746765

Supplemental Content

Support Center